Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-10

Clinical Trial Update: Bioresorbable Glass Fiber Matrix in the Treatment of Diabetic Foot Ulcers [NA]

View source ↗

Summary

A completed clinical trial evaluating a bioresorbable glass fiber matrix for diabetic foot ulcers has posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bioresorbable Glass Fiber Matrix

Snippet

Sponsor: ETS Wound Care, LLC | Conditions: Diabetic Foot Ulcer, Ulcer Foot | NA | Status: COMPLETED | Results posted: 2025-11-10